Cargando…
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel
BACKGROUND: Checkpoint blockade immunotherapy has had a significant impact on the survival of a subset of patients with advanced cancers. It has been particularly effective in immunogenic cancer types that present large numbers of somatic mutations in their genomes. To date, all conventional immunot...
Autores principales: | Brouwer, Thomas P., Vahrmeijer, Alexander L., de Miranda, Noel F. C. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985121/ https://www.ncbi.nlm.nih.gov/pubmed/33710604 http://dx.doi.org/10.1007/s13402-021-00587-z |
Ejemplares similares
-
Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?
por: von Amsberg, Gunhild, et al.
Publicado: (2022) -
Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
por: Mahipal, Amit, et al.
Publicado: (2019) -
Light at end of the tunnel
por: Hassard, J
Publicado: (1989) -
Light at the end of the tunnel
por: Manohar, Balaji
Publicado: (2013) -
The Light at the End of the Tunnel
por: Mando, Rufaat, et al.
Publicado: (2019)